Stimulation of human red blood cells leads to Ca2+-mediated intercellular adhesion

Cell Calcium

Volumn 50, Issue 1, 2011, Pages 54-61

  Steffen, Patrick ^a   Jung, Achim ^a   Nguyen, Duc Bach ^a   Müller, Torsten ^b   Bernhardt, Ingolf ^a   Kaestner, Lars ^c   Wagner, Christian ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b JPK Instruments AG   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Blood clot; Calcium signaling; Lysophosphatidic acid; Red blood cells; Single cell force spectroscopy

Indexed keywords

CALCIUM ION; LYSOPHOSPHATIDIC ACID;

ARTICLE; BLOOD CLOT; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ADHESION; CELL STIMULATION; CONTROLLED STUDY; ERYTHROCYTE; HOLOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPECTROSCOPY; THROMBOCYTE ACTIVATION;

EID: 79960205820     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2011.05.002     Document Type: Article

References (53)

1. McWhirter J.L., Noguchi H., Gompper G. Flow-induced clustering and alignment of vesicles and red blood cells in microcapillaries. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:6039-6043.
2. Snabre P., Grossmann G.H., Mills P. Effects of dextran polydispersity on red blood-cell aggregation. Colloid Polym. Sci. 1985, 263:478-483.
3. Pribush A., Zilberman-Kravits D., Meyerstein N. The mechanism of the dextran-induced red blood cell aggregation. Eur. Biophys. J. 2007, 36:85-94.
4. Evans E. Detailed mechanics of membrane-membrane adhesion and separation. 1. Continuum of molecular cross-bridged. 2. Discrete kinetically trapped molecular cross-bridges. Biophys. J. 1985, 48:175-192.
5. Ataga K.I., Cappellini M.D., Rachmilewitz E.A. Beta-thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. Br. J. Haematol. 2007, 139:3-13.
6. Duke W.W. The relation of blood platelets to hemorrhagic disease. JAMA 1910, 55:1185-1192.
7. Hellem A.J., Borchgrevink C.F., Ames S.B. The role of red cells in haemostasis: the relation between haematocrit, bleeding time and platelet adhesiveness. Br. J. Haematol. 1961, 7:42-50.
8. Livio M., Gotti E., Marchesi D., Mecca G., Remuzzi G., de Gaetano G. Uraemic bleeding: role of anaemia and beneficial effect of red cell transfusions. Lancet 1982, 2:1013-1015.
9. Kaestner L., Tabellion W., Lipp P., Bernhardt I. Prostaglandin E2 activates channel-mediated calcium entry in human erythrocytes: an indication for a blood clot formation supporting process. Thromb. Haemost. 2004, 92:1269-1272.
10. Kaestner L., Bollensdorff C., Bernhardt I. Non-selective voltage-activated cation channel in the human red blood cell membrane. Biochim. Biophys. Acta 1999, 1417:9-15.
11. Kaestner L., Christophersen P., Bernhardt I., Bennekou P. The non-selective voltage-activated cation channel in the human red blood cell membrane: reconciliation between two conflicting reports and further characterisation. Bioelectrochemistry 2000, 52:117-125.
12. Kaestner L., Bernhardt I. Ion channels in the human red blood cell membrane: their further investigation and physiological relevance. Bioelectrochemistry 2002, 55:71-74.
13. Dyrda A., Cytlak U., Ciuraszkiewicz A., Lipinska A., Cueff A., Bouyer G., Egee S., Bennekou P., Lew V.L., Thomas S.L.Y. Local membrane deformations activate Ca2+-dependent K+ and anionic currents in intact human red blood cells. PLoS One 2010, 5:e9447.
14. Oonishi T., Sakashita K., Ishioka N., Suematsu N., Shio H., Uyesaka N. Production of prostaglandins E1 and E2 by adult human red blood cells. Prostaglandins Other Lipid Mediat. 1998, 56:89-101.
15. Dholakia K., Spalding G., MacDonald M. Optical tweezers: the next generation. Phys. World 2002, 15:31-35.
16. Lang P.A., Kaiser S., Myssina S., Wieder T., Lang F., Huber S.M. Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am. J. Physiol. Cell Physiol. 2003, 285:C1553-C1560.
17. Chung S.M., Bae O.N., Lim K.M., Noh J.Y., Lee M.Y., Jung Y.S., Chung J.H. Lysophosphatidic acid induces thrombogenic activity through phosphatidylserine exposure and procoagulant microvesicle generation in human erythrocytes. Arterioscler. Thromb. Vasc. Biol. 2007, 27:414-421.
18. Friedrichs J., Helenius J., Muller D.J. Quantifying cellular adhesion to extracellular matrix components by single-cell force spectroscopy. Nat. Protoc. 2010, 5:1353-1361.
19. Gardos G. The function of calcium in the potassium permeability of human erythrocytes. Biochim. Biophys. Acta 1958, 30:653-654.
20. Hoffman J.F., Joiner W., Nehrke K., Potapova O., Foye K., Wickrema A. The hSK4 (KCNN4) isoform is the Ca2+-activated K+ channel (Gardos channel) in human red blood cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:7366-7371.
21. Woon L.A., Holland J.W., Kable E.P., Roufogalis B.D. Ca2+ sensitivity of phospholipid scrambling in human red cell ghosts. Cell Calcium 1999, 25:313-320.
22. Haest C.W.M. Distribution and movement of membrane lipids. Red Cell Membrane Transport in Health and Disease 2003, 1-26. Springer Verlag, Berlin.
23. Yang L., Andrews D.A., Low P.S. Lysophosphatidic acid opens a Ca2+ channel in human erythrocytes. Blood 2000, 95:2420-2425.
24. Dixon R., Young K., Brunskill N. Lysophosphatidic acid-induced calcium mobilization and proliferation in kidney proximal tubular cells. Am. J. Physiol. 1999, 276:F191-F198.
25. Meerschaert K., De Corte V., De Ville Y., Vandekerckhove J., Gettemans J. Gelsolin and functionally similar actin-binding proteins are regulated by lysophosphatidic acid. EMBO J. 1998, 17:5923-5932.
26. Eichholtz T., Jalink K., Fahrenfort I., Moolenaar W.H. The bioactive phospholipid lysophosphatidic acid is released from activated platelets. Biochem. J. 1993, 291:677-680.
27. Gaits F., Fourcade O., LeBalle F., Gueguen G., Gaige B., GassamaDiagne A., Fauvel J., Salles J., Mauco G., Simon M., Chap H. Lysophosphatidic acid as a phospholipid mediator: pathways of synthesis. FEBS Lett. 1997, 410:54-58.
28. Kaestner L., Tabellion W., Weiss E., Bernhardt I., Lipp P. Calcium imaging of individual erythrocytes: problems and approaches. Cell Calcium 2006, 39:13-19.
29. Kaestner L. Cation channels in erythrocytes - historical and future perspective. Open Biol. J. 2011, 4:27-34.
30. Berg C., Engels I., Rothbart A., Lauber K., Renz A., Schlosser S., Schulze-Osthoff K., Wesselborg S. Human mature red blood cells express caspase-3 and caspase-8, but are devoid of mitochondrial regulators of apoptosis. Cell Death Differ. 2001, 8:1197-1206.
31. Schatzmann H.J. ATP-dependent Ca2+-extrusion from human red cells. Experientia 1966, 22:364-365.
32. Tiffert T., Bookchin R.M., Lew V.L. Calcium homeostasis in normal and abnormal human red cells. Red Cell Membrane Transport in Health and Disease 2003, 373-405. Springer Verlag, Berlin.
33. Lew V.L., Daw N., Perdomo D., Etzion Z., Bookchin R.M., Tiffert T. Distribution of plasma membrane Ca2+ pump activity in normal human red blood cells. Blood 2003, 102:4206-4213.
34. Bitbol M., Fellmann P., Zachowski A., Devaux P.F. Ion regulation of phosphatidylserine and phosphatidylethanolamine outside inside translocation in human-erythrocytes. Biochim. Biophys. Acta 1987, 904:268-282.
35. Leinders T., Vankleef R.G.D.M., Vijverberg H.P.M. Single Ca(2+)-activated K+ channels in human erythrocytes: Ca2+ dependence of opening frequency but not of open lifetimes. Biochim. Biophys. Acta 1992, 1112:67-74.
36. Kaestner L., Juzeniene A., Moan J. Erythrocytes - the " house elves" of photodynamic therapy. Photochem. Photobiol. Sci. 2004, 3:981-989.
37. Stout J.G., Zhou Q.S., Wiedmer T., Sims P.J. Change in conformation of plasma membrane phospholipid scramblase induced by occupancy of its Ca2+ building site. Biochemistry 1998, 37:14860-14866.
38. Murakami T., Hatanaka M., Murachi T. The cytosol of human-erythrocytes contains a highly Ca2+-sensitive thiol protease (calpain I) and its specific inhibitor protein (calpastatin). J. Biochem. 1981, 90:1809-1816.
39. Cueff A., Seear R., Dyrda A., Bouyer G., Egee S., Esposito A., Skepper J., Tiffert T., Lew V.L., Thomas S.L. Effects of elevated intracellular calcium on the osmotic fragility of human red blood cells. Cell Calcium 2010, 47:29-36.
40. Lansman J., Haynes D.H. Kinetics of a Ca2+-triggered membrane aggregation reaction of phospholipid membranes. Biochim. Biophys. Acta 1975, 394:335-347.
41. Ohki S., Duzgunes N., Leonards K. Phospholipid vesicle aggregation: effect of monovalent and divalent ions. Biochemistry 1982, 21:2127-2133.
42. Babincova M., Machova E. Dextran enhances calcium-induced aggregation of phosphatidylserine liposomes: possible implications for exocytosis. Physiol. Res. 1999, 48:319-321.
43. Govekar R.B., Zingde S.M. Protein kinase C isoforms in human erythrocytes. Ann. Hematol. 2001, 80:531-534.
44. Klarl B.A., Lang P.A., Kempe D.S., Niemoeller O.M., Akel A., Sobiesiak M., Eisele K., Podolski M., Huber S.M., Wieder T., Lang F. Protein kinase C mediates erythrocyte " programmed cell death" following glucose depletion. Am. J. Physiol. Cell Physiol. 2006, 290:C244-253.
45. Kleinbongard P., Schulz R., Muench M., Rassaf T., Lauer T., Goedecke A., Kelm M. Red blood cells express a functional endothelial nitric oxide synthase. Eur. Heart J. 2006, 27:127.
46. Makhro A., Wang J., Vogel J., Boldyrev A.A., Gassmann M., Kaestner L., Bogdanova A. Functional NMDA receptors in rat erythrocytes. Am. J. Physiol. Cell Physiol. 2010, 298. 10.1152/ajpcell.00407.2009.
47. Snabre P., Bitbol M., Mills P. Cell disaggregation behavior in shear. Biophys. J. 1987, 51:795-807.
48. Mackman N. Triggers, targets and treatments for thrombosis. Nature 2008, 451:914-918.
49. Noh J.Y., Lim K.M., Bae O.N., Chung S.M., Lee S.W., Joo K.M., Lee S.D., Chung J.H. Procoagulant and prothrombotic activation of human erythrocytes by phosphatidic acid. Am. J. Physiol. Heart Circ. Physiol. 2010, 299:H347-H355.
50. Bogdanova A., Makhro A., Goede J., Wang J., Boldyrev A., Gassmann M., Kaestner L. NMDA receptors in mammalian erythrocytes. Clin. Biochem. 2009, 42:1858-1859.
51. Luvira V., Chamnanchanunt S., Thanachartwet V., Phumratanaprapin W., Viriyavejakul A. Cerebral venous sinus thrombosis in severe malaria. Southeast Asian J. Trop. Med. Public Health 2009, 40:893-897.
52. Eldor A., Rachmilewitz E.A. The hypercoagulable state in thalassemia. Blood 2002, 99:36-43.
53. Taher A.T., Otrock Z.K., Uthman I., Cappellini M.D. Thalassemia and hypercoagulability. Blood Rev. 2008, 22:283-292.